118th Congress Health
H.R. 1092: BENEFIT Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.
After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Brad Wenstrup R-OHOriginal
- Gus Bilirakis R-FL
- Chellie Pingree D-ME
- Rudy Yakym R-IN
- Mark Green R-TN
- Deborah Ross D-NC
- Tim Burchett R-TN
- Jared Golden D-ME
- Don Bacon R-NE
- Emanuel Cleaver D-MO
- Susan Wild D-PA
- Tony Cárdenas D-CA
- Brian Fitzpatrick R-PA
- Josh Harder D-CA
- Brian Higgins D-NY
- Eleanor Norton D-DC
- Shri Thanedar D-MI
- Dean Phillips D-MN
- Tom Cole R-OK
- Josh Gottheimer D-NJ
- Jefferson Van Drew R-NJ
- Jenniffer González-Colón R-PR
- Doug LaMalfa R-CA
- Michael Lawler R-NY
- John James R-MI
- Glenn Thompson R-PA
- Debbie Wasserman Schultz D-FL
- Paul Tonko D-NY
- Greg Landsman D-OH
- Troy Balderson R-OH
- Glenn Grothman R-WI
Who scored on this bill
- 1Doris Matsui SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Doris Matsui
History
- Introduced in the House by Doris Matsui.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.